triazoles has been researched along with Lymphoma, Mantle-Cell in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 8 (72.73) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Abeykoon, JP; Boughey, JC; Boysen, J; Carr, RM; Couch, FJ; Dasari, S; Feldman, AL; Goetz, MP; Hou, X; Hu, C; Kapoor, P; King, RL; Kumar, S; Manske, MK; Mladek, AC; Molina, JR; Nowakowski, KE; Paludo, J; Parikh, SA; Patnaik, MM; Phillips, JL; Ravindran, A; Robinson, SI; Sarkaria, JN; Stenson, MJ; Wang, L; Weroha, SJ; Witzig, TE; Wu, X; Yu, J | 1 |
| Golemis, EA; Liu, H; Liu, L; Lu, Z; Shi, X; Tu, Z; Zhang, P | 1 |
| Andreeff, M; Arai, H; Ciurea, S; Han, L; Kaga, N; Kazuno, S; Kikkawa, M; Konopleva, M; Miida, T; Saitoh, K; Sekihara, K; Tabe, Y; Taka, H; Yamamoto, S | 1 |
| Kadri, S; Landesman, Y; Lee, J; Lu, P; Maltsev, N; Ming, M; Shacham, S; Sharma, S; Sukhanova, M; Wang, W; Wang, YL; Wu, W; Xie, B | 1 |
| Arribas, AJ; Bertoni, F; Cascione, L; Curti, E; Gaudio, E; Priebe, V; Rossi, D; Spriano, F; Stathis, A; Tarantelli, C; Zhang, L; Zucca, E | 1 |
| Choi, CM; Choi, YJ; Hong, JY; Kim, DH; Lee, JC; Rho, JK; Suh, C; Yoon, DH | 1 |
| Andreeff, M; Dilip, A; Ishizawa, J; Kauffman, M; Kimura, S; Kojima, K; Kwak, LW; McDonnell, TJ; Neelapu, SS; Quintás-Cardama, A; Ruvolo, V; Shacham, S; Tabe, Y; Yokoo, M; Yoshimura, M | 1 |
| Bhalla, KN; Bradner, JE; Coarfa, C; Devaraj, SG; Fiskus, W; Krieger, S; Li, L; Qi, J; Rajapakshe, K; Saenz, DT; Shah, B; Sharma, S; Sun, B; Wang, ML; Zhang, L | 1 |
| Ford, RJ; Kauffman, M; Lee, J; Li, C; Ou, Z; Pham, LV; Shacham, S; Sun, L; Tamayo, AT; Wang, M; Zhang, K; Zhang, L | 1 |
| Dreyling, M; Granot, G; Levi, I; Mor-Tzuntz, R; Nathan, I; Shpilberg, O; Vazana-Barad, L | 1 |
| Gallamini, A; Lo Nigro, C; Mattei, D; Mordini, N; Osenda, M; Pugno, F; Viscoli, C | 1 |
11 other study(ies) available for triazoles and Lymphoma, Mantle-Cell
| Article | Year |
|---|---|
Salicylates enhance CRM1 inhibitor antitumor activity by induction of S-phase arrest and impairment of DNA-damage repair.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Cycle Checkpoints; Choline; DNA Repair; DNA Replication; DNA, Neoplasm; Drug Combinations; Drug Synergism; Exportin 1 Protein; Gene Expression Regulation, Neoplastic; Humans; Hydrazines; Karyopherins; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Male; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Proteins; Phthalazines; Piperazines; Random Allocation; Receptors, Cytoplasmic and Nuclear; S Phase Cell Cycle Checkpoints; Salicylates; Triazoles; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2021 |
HSP90 inhibition downregulates DNA replication and repair genes via E2F1 repression.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; DNA Repair; DNA Replication; E2F1 Transcription Factor; Gene Expression Regulation, Neoplastic; HSP90 Heat-Shock Proteins; Humans; Lymphoma, Mantle-Cell; Mice; Mice, Nude; Signal Transduction; Triazoles; Xenograft Model Antitumor Assays | 2021 |
Targeting mantle cell lymphoma metabolism and survival through simultaneous blockade of mTOR and nuclear transporter exportin-1.
Topics: Acrylates; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Cell Line, Tumor; Cell Proliferation; Cell Survival; Energy Metabolism; Exportin 1 Protein; Humans; Karyopherins; Lymphoma, Mantle-Cell; Morpholines; Proteome; Proteomics; Pyrimidines; Receptors, Cytoplasmic and Nuclear; Signal Transduction; TOR Serine-Threonine Kinases; Triazoles | 2017 |
XPO1 Inhibitor Selinexor Overcomes Intrinsic Ibrutinib Resistance in Mantle Cell Lymphoma via Nuclear Retention of IκB.
Topics: Adenine; Apoptosis; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Down-Regulation; Drug Resistance, Neoplasm; Exportin 1 Protein; Humans; Hydrazines; I-kappa B Proteins; Karyopherins; Lymphoma, Mantle-Cell; NF-kappa B; Piperidines; Protein Subunits; Pyrazoles; Pyrimidines; Receptors, Cytoplasmic and Nuclear; Triazoles | 2018 |
The Bruton tyrosine kinase inhibitor zanubrutinib (BGB-3111) demonstrated synergies with other anti-lymphoma targeted agents.
Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Antineoplastic Combined Chemotherapy Protocols; Bridged Bicyclo Compounds, Heterocyclic; Cell Proliferation; Drug Synergism; Humans; Hydrazines; Lymphoma, B-Cell; Lymphoma, Mantle-Cell; Niacinamide; Piperidines; Pyrazoles; Pyrimidines; Sulfonamides; Triazoles; Tumor Cells, Cultured | 2019 |
Efficacy of the novel CDK7 inhibitor QS1189 in mantle cell lymphoma.
Topics: Adenine; Antineoplastic Agents; Bridged Bicyclo Compounds, Heterocyclic; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin-Dependent Kinase-Activating Kinase; Cyclin-Dependent Kinases; Drug Resistance, Neoplasm; Drug Synergism; Humans; Lymphoma, Mantle-Cell; Phosphorylation; Piperidines; Pyrazoles; Pyrimidines; RNA Polymerase II; Sulfonamides; Triazoles | 2019 |
Induction of p53-mediated transcription and apoptosis by exportin-1 (XPO1) inhibition in mantle cell lymphoma.
Topics: Acrylates; Animals; Apoptosis; Exportin 1 Protein; Gene Expression Regulation, Neoplastic; Genes, p53; Humans; Karyopherins; Lymphoma, Mantle-Cell; Mice; Mice, Transgenic; Mutation; Prognosis; Receptors, Cytoplasmic and Nuclear; Transcription, Genetic; Triazoles; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2014 |
Synergistic activity of BET protein antagonist-based combinations in mantle cell lymphoma cells sensitive or resistant to ibrutinib.
Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Animals; Antineoplastic Agents; Azepines; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Drug Resistance, Neoplasm; Drug Synergism; Enzyme Inhibitors; Histone Deacetylase Inhibitors; Humans; Lymphoma, Mantle-Cell; Mice, Inbred NOD; Mice, SCID; NF-kappa B; Nuclear Proteins; Piperidines; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; Pyrazoles; Pyrimidines; Transcription Factor RelA; Transcription Factors; Triazoles | 2015 |
Novel selective inhibitors of nuclear export CRM1 antagonists for therapy in mantle cell lymphoma.
Topics: Acrylates; Animals; Apoptosis; Cell Line, Tumor; Exportin 1 Protein; Humans; Karyopherins; Lymphoma, Mantle-Cell; Mice; NF-kappa B; Receptors, Cytoplasmic and Nuclear; RNA, Small Interfering; Triazoles; Tumor Suppressor Protein p53 | 2013 |
Mechanism of the antitumoral activity of deferasirox, an iron chelation agent, on mantle cell lymphoma.
Topics: Antineoplastic Agents; Apoptosis; Benzoates; Cell Cycle; Cell Line, Tumor; Cell Survival; Cyclin D1; Deferasirox; Gene Expression Regulation, Neoplastic; Humans; Iron; Iron Chelating Agents; Lymphoma, Mantle-Cell; Proteasome Endopeptidase Complex; Proteolysis; RNA, Messenger; Triazoles | 2013 |
Successful treatment of Acremonium fungemia with voriconazole.
Topics: Acremonium; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Female; Fungemia; Humans; Lymphoma, Mantle-Cell; Middle Aged; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Triazoles; Voriconazole | 2003 |